Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|
Operating Income | $15.2M | $15.4M | ($286.4M) | ($210.2M) | ($189.1M) |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, LifeStance Health Group, Inc.'s last 12-month Operating Income is ($63.5M), based on the financial report for Sep 30, 2024 (Q3 2024).
Over the last year, LifeStance Health Group, Inc.'s Operating Income growth was (68.7%). The average annual Operating Income growth rates for LifeStance Health Group, Inc. have been N/A over the past three years, N/A over the past five years.
Over the last year, LifeStance Health Group, Inc.'s Operating Income growth was (68.7%), which is lower than industry growth of (0.0%). It indicates that LifeStance Health Group, Inc.'s Operating Income growth is Bad.